Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 85

Sort by

Sort Order Select

Journal Articles

Assessing Patient and Provider Perspectives, Clinical Practice, Behaviors, and Knowledge on Hemophilia A Care

Tariqa A Ackbarali, PhDc), Stacy E. Croteau, MD, Steven W. Pipe, MD, Kelly Tickle, MSN, APN, CWON, PCNS-BS, PPCNP-BC, Lori Long, Sonji Wilkes, BS, Kate Nammacher, MPH, Neil Frick, Katie Kowalski, Wendy Turell

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-141657

Published: 2020

Journal Articles

Treatment with CPX-351 Induces Deep Responses and TP53 Mutation Clearance in Patients with t-AML and AML MRC, Including Younger Patients and Those with Pre-Existing MPNs: A Real-World Experience

Gee Youn (Geeny) Kim, PharmD, Jamie L. Koprivnikar, MD, Rebecca Testi, MSN, RN, APN-C, OCN, Tara McCabe, FNP-C, MSN, RN, BSN, Grace Perry, MSN, RN, APN-C, OCN, Danielle Marcotulli, MSN, RN, FNP-BC, AOCNP, Elizabeth Jones, BSN, RN, OCN, Xue Geng, MS, Ming Tan, James K. McCloskey, MD

Blood (2020) 136 (Supplement 1): 49–50.

https://doi.org/10.1182/blood-2020-142891

Published: 2020

Journal Articles

Reduction of Clostridium Difficile Infection in an Academic Medical Center Blood and Marrow Transplant Population

Brandi Handel, MSN, RN, Nicole McEntee, BSN, RN, OCN, BMTCN, Anne Tyno, RN, MSN, APN-C, Patricia Andrews, BSN, RN, OCN, Patricia Lafaro, BS, RN, CIC, Vimal Patel, MD, Dale G Schaar, MD PhD, Roger Strair, MD PhD, Dennis Cooper, MD

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-142972

Published: 2020

Journal Articles

Prospective Randomized Comparative Study of Myeloablative Fludarabine/Busulfan (Flu/Bu4) and Fludarabine/Busulfan/Total Body Irradiation (Flu/Bu4/TBI) Conditioning Regimen for Patients with Myeloid Diseases

Hyung C. Suh, MDPhD, Scott D. Rowley, MD, Sukhdeep Kaur, MD, Brittany Lukasik, Phyllis McKiernan, Michele Boonstra, APN, Milissa Baker, MSN, ANP, Mary E Dilorenzo, APN, Alan Skarbnik, MD, Themba Nyirenda, PhD, David H. Vesole, MD PhD, Michele L. Donato, MD

Blood (2020) 136 (Supplement 1): 9.

https://doi.org/10.1182/blood-2020-142272

Published: 2020

Journal Articles

Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-World Analysis

Adam Zayac, MD, Andrew Matthew Evens, DO,MMSc, Andrzej Stadnik, MPH, BS, Stephen D. Smith, MD, Deepa Jagadeesh, MDMPH, Lori A. Leslie, MD, Catherine Wei, MD MA, Seo-Hyun Kim, MD, Seema Naik, MD, Suchitra Sundaram, MD, Nishitha Reddy, MD, Umar Farooq, MD, Vaishalee P. Kenkre, MD, Narendranath Epperla, MDMS, Kristie A. Blum, MD, Nadia Khan, MD, Daulath Singh, MD, Juan Pablo Alderuccio, MD, Amandeep Godara, MD, Maryam Yazdy, MD, Catherine Diefenbach, MD, Emma Rabinovich, MD, Gaurav Varma, MDMPH, Reem Karmali, MD, Yusra Shao, MD, Asaad Trabolsi, MD, Madelyn Burkart, MD, Peter Martin, FRCPC, MD MS, Sarah Stettner, Ayushi Chauhan, MBBS, Yun Kyong Choi, MD, Allandria Straker-Edwards, MS, Andreas Klein, MD, Michael C. Churnetski, Kirsten M Boughan, DO, Stephanie Berg, DO, Brad M. Haverkos, MDMPH,MS, Victor M. Orellana-Noia, MD, Christopher D'Angelo, MD, David A. Bond, MD, Seth M Maliske, MD, Ryan Vaca, MD, Gabriela Magarelli, APN, Amy Sperling, BS, Max J. Gordon, MD, Kevin A. David, MD, Paolo Caimi, MD, Manali Kamdar, MD, Craig A. Portell, MD, Parameswaran Venugopal, MD, Izidore S. Lossos, MD, Adam J Olszewski, MD

Blood (2019) 134 (Supplement_1): 402.

https://doi.org/10.1182/blood-2019-122990

Published: 2019

Journal Articles

Evolution of Moderate Aplastic Anemia into Subclinical PNH/AA and Successful Treatment with Reduced Intensity Haplo-HSCT: A Pediatric Case Report

Meghana Srinivas, Jennifer Krajewski, MD, Nancy Durning, APN, Melanie Hankewycz, APN, Alfred Gillio, MD

Blood (2019) 134 (Supplement_1): 5027.

https://doi.org/10.1182/blood-2019-130407

Published: 2019

Journal Articles

Utilizing a Peer Patient Advocate to Develop Sickle Cell Transition Educational Materials

Ronisha Edwards-Elliott, BA,MA, Robin Johnson, DNP,APN,CPNP, Divya Bhandar, Sharice Bradford, EdD, Caroline Hodgson, DNP, APN, CPNP, Susan Walsh, DNP,CPNP, Patil Crystal, PhD, Angela Rivers, MD

Blood (2019) 134 (Supplement_1): 5807.

https://doi.org/10.1182/blood-2019-128533

Published: 2019

Journal Articles

Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease

Jin Han, PharmD, PhD, Santosh L. Saraf, MD, Michel Gowhari, DO, Faiz Ahmed Hussain, MD, Shivi Jain, MD, Laura Kavoliunaite, APN, Robert E. Molokie, MD, Victor R Gordeuk, MD

Blood (2019) 134 (Supplement_1): 3390.

https://doi.org/10.1182/blood-2019-122249

Published: 2019

Journal Articles

Fitness and Anthracycline Use in Front-Line Therapy for Older Patients with Classical Hodgkin Lymphoma: A US Multi-Center Retrospective Analysis

Blood (2019) 134 (Supplement_1): 4027.

https://doi.org/10.1182/blood-2019-123572

Published: 2019

Journal Articles

Incorporation of Posttransplant Cyclophosphamide (PCy) As Part of Standard Immunoprophylaxis (IP) for All Allogeneic Transplants: A Retrospective, Single Institution Study

Dennis Cooper, MD, Jackie Manago, RN, BSN, Vimal Patel, MD, Dale Schaar, MD PhD, Tracy Krimmel, AOCN, APRN-BC, Mary Kate McGrath, RN, APN, Anne Tyno, RN, MSN, APN-C, Roger Strair, MD PhD

Blood (2019) 134 (Supplement_1): 4485.

https://doi.org/10.1182/blood-2019-130598

Published: 2019

Journal Articles

North American Practice Patterns for PET-2 Positive Hodgkin Lymphoma

Blood (2019) 134 (Supplement_1): 1553.

https://doi.org/10.1182/blood-2019-131276

Published: 2019

Journal Articles

Severe Bleeding Events in Hemophilia Α Patients Receiving Emicizumab Prophylaxis

Karen L. Zimowski, MD, Glaivy M. Batsuli, MD, Paulette Bryant, MD, Jenny McDaniel, MD, Kelly Tickle, MSN, APN, PPCNP-BC, Shannon L. Meeks, MD, Robert F. Sidonio, Jr., MD MSc

Blood (2019) 134 (Supplement_1): 1126.

https://doi.org/10.1182/blood-2019-126659

Published: 2019

Journal Articles

The Atlanta Protocol: Immune Tolerance Induction in Pediatric Patients with Hemophilia a and Inhibitors on Emicizumab

Glaivy M. Batsuli, MD, Karen L. Zimowski, MD, Kelly Tickle, MSN, APN, PPCNP-BC, Shannon L. Meeks, MD, Robert F. Sidonio, Jr., MD

Blood (2018) 132 (Supplement 1): 634.

https://doi.org/10.1182/blood-2018-99-114249

Published: 2018

Journal Articles

Maintaining Perioperative Hemostasis in Patients with Severe Hemophilia A and Inhibitors Receiving Emicizumab Prophylaxis

Karen L. Zimowski, MD, Glaivy M. Batsuli, MD, Mark T. Reding, MD, Jatin Rana, MD, Michael U. Callaghan, MD, Kelly Tickle, MSN, APN, PPCNP-BC, Shannon L. Meeks, MD, Robert F. Sidonio, Jr., MD

Blood (2018) 132 (Supplement 1): 635.

https://doi.org/10.1182/blood-2018-99-115089

Published: 2018

Journal Articles

Blinatumumab Induces Responses in Extramedulary B-Cell Acute Lymphoid Leukemia (B-ALL) and Lymphoid Blast Crisis Chronic Myelogenous Leukemia (CML), and Rarely Results in CD19 Negative Relapse

Jamie Koprivnikar, MD, Danielle Marcotulli, APN, Elizabeth Jones, RN, Grace Perry, APN, Yen-Hong Kuo, PhD, Joelle Gagnon, NP, Maritess Aviador, RN, Genique Stanislaus, ANP, James McCloskey, MD

Blood (2018) 132 (Supplement 1): 2703.

https://doi.org/10.1182/blood-2018-99-120172

Published: 2018

Journal Articles

Decreased Temperature Associated with Increased ED Visits By Patients with Sickle Cell Disease

Jessica Lander, MD MPH, Tanisha Jones, MSN, APN, F-NP, Gabrielle Lapping-Carr, MD, Radhika Peddinti, MD, Wendy S Darlington, MD MAPP

Blood (2018) 132 (Supplement 1): 2385.

https://doi.org/10.1182/blood-2018-99-115517

Published: 2018

Journal Articles

Largest Reported Series of Adults Who Received Treatment with Eculizumab (ECU) for Hematopoietic Cell Transplantation-Associated Thrombotic Microangiopathy (TA-TMA). a Single Center Experience

Alan P Skarbnik, MD, Mary E Dilorenzo, APN, Michele Simone, APN, Scott D. Rowley, MD, David H. Vesole, MD PhD, Maribel Pereiras, Pharm D, Tracy Andrews, MSc, Andrew L. Pecora, MD, Michele L. Donato, MD

Blood (2018) 132 (Supplement 1): 3383.

https://doi.org/10.1182/blood-2018-99-113639

Published: 2018

Journal Articles

Our Hands, Our Health: Developing a Promising Group Healthcare Model for Pediatric to Adult Transition in a Sickle Cell Disease Clinic

Angela Rivers, MD, Ronisha Edwards, MSW, Divya Bhandar, Sharice Bradford, EdD, Brigid Packer, APRN, CNP, Robin Johnson, DNP, APN, CPNP, Nicole Rodos, CPNPAC, DNP, Susan Walsh, DNP, CPNP, Patil Crystal, PhD

Blood (2018) 132 (Supplement 1): 4713.

https://doi.org/10.1182/blood-2018-99-111848

Published: 2018

Journal Articles

Food Insecurity and Quality of Life Among Children and Young Adults with Sickle Cell Disease

Shelby Gruntorad, MS, Tanisha Jones, MSN, APN, F-NP, Gabrielle Lapping-Carr, MD, Radhika Peddinti, MD, Wendy S Darlington, MD MAPP

Blood (2018) 132 (Supplement 1): 2283.

https://doi.org/10.1182/blood-2018-99-113413

Published: 2018

Journal Articles

Cyclophosphamide Based Regimens Compared to Plerixafor-Based Regimens for Stem Cell Mobilization in Patients with Multiple Myeloma Result in Higher CD34+ Cell Yield, Lower Cost and Similar Outcome Post Autologous Transplantation

Rima M Panchal, MD, Phyllis McKiernan, APN, MSN, David Siegel, MD PhD, Scott D. Rowley, MD, David H. Vesole, MD PhD, Tracy Andrews, PhD, Andrea Ortega, RN, Alan P Skarbnik, MD, Noa Biran, MD, Joshua R Richter, MD, Nino Aleksidze, MD, Andrew L. Pecora, MD, Andre Goy, MD, Maribel Pereiras, Pharm D, Michele L. Donato, MD

Blood (2017) 130 (Supplement 1): 3283.

https://doi.org/10.1182/blood.V130.Suppl_1.3283.3283

Published: 2017

NARROW

Assessing Patient and Provider Perspectives, Clinical Practice, Behaviors, and Knowledge on Hemophilia A Care

Treatment with CPX-351 Induces Deep Responses and TP53 Mutation Clearance in Patients with t-AML and AML MRC, Including Younger Patients and Those with Pre-Existing MPNs: A Real-World Experience

Reduction of Clostridium Difficile Infection in an Academic Medical Center Blood and Marrow Transplant Population

Prospective Randomized Comparative Study of Myeloablative Fludarabine/Busulfan (Flu/Bu4) and Fludarabine/Busulfan/Total Body Irradiation (Flu/Bu4/TBI) Conditioning Regimen for Patients with Myeloid Diseases

Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-World Analysis

Evolution of Moderate Aplastic Anemia into Subclinical PNH/AA and Successful Treatment with Reduced Intensity Haplo-HSCT: A Pediatric Case Report

Utilizing a Peer Patient Advocate to Develop Sickle Cell Transition Educational Materials

Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease

Fitness and Anthracycline Use in Front-Line Therapy for Older Patients with Classical Hodgkin Lymphoma: A US Multi-Center Retrospective Analysis

Incorporation of Posttransplant Cyclophosphamide (PCy) As Part of Standard Immunoprophylaxis (IP) for All Allogeneic Transplants: A Retrospective, Single Institution Study

North American Practice Patterns for PET-2 Positive Hodgkin Lymphoma

Severe Bleeding Events in Hemophilia Α Patients Receiving Emicizumab Prophylaxis

The Atlanta Protocol: Immune Tolerance Induction in Pediatric Patients with Hemophilia a and Inhibitors on Emicizumab

Maintaining Perioperative Hemostasis in Patients with Severe Hemophilia A and Inhibitors Receiving Emicizumab Prophylaxis

Blinatumumab Induces Responses in Extramedulary B-Cell Acute Lymphoid Leukemia (B-ALL) and Lymphoid Blast Crisis Chronic Myelogenous Leukemia (CML), and Rarely Results in CD19 Negative Relapse

Decreased Temperature Associated with Increased ED Visits By Patients with Sickle Cell Disease

Largest Reported Series of Adults Who Received Treatment with Eculizumab (ECU) for Hematopoietic Cell Transplantation-Associated Thrombotic Microangiopathy (TA-TMA). a Single Center Experience

Our Hands, Our Health: Developing a Promising Group Healthcare Model for Pediatric to Adult Transition in a Sickle Cell Disease Clinic

Food Insecurity and Quality of Life Among Children and Young Adults with Sickle Cell Disease

Cyclophosphamide Based Regimens Compared to Plerixafor-Based Regimens for Stem Cell Mobilization in Patients with Multiple Myeloma Result in Higher CD34+ Cell Yield, Lower Cost and Similar Outcome Post Autologous Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only